Molecular imaging probes for 31P contrast
<p><sup>31</sup>P magnetic resonance has yet to realise its clinical potential principally due to the relatively low sensitivity of the <sup>31</sup>P nucleus. While <sup>31</sup>P-MRS can uniquely provide vital information regarding in vivo phosphorus met...
Príomhchruthaitheoir: | Tear, L |
---|---|
Rannpháirtithe: | Faulkner, S |
Formáid: | Tráchtas |
Teanga: | English |
Foilsithe / Cruthaithe: |
2018
|
Ábhair: |
Míreanna comhchosúla
Míreanna comhchosúla
-
Magnetic Resonance Imaging Contrast Agents: A Review of Literature
de réir: Zahra Sahraei, et al.
Foilsithe / Cruthaithe: (2015-10-01) -
Interval between contrast administration and T1-weighted MRI for cerebral adrenoleukodystrophy: a single-case observation
de réir: Marco Moscatelli, et al.
Foilsithe / Cruthaithe: (2023-10-01) -
Comparison of gadolinium-based contrast agents for MR cholangiography in saline, blood and bile: a phantom study
de réir: Johannes M. Froehlich, et al.
Foilsithe / Cruthaithe: (2023-04-01) -
Gadolinium-enhanced cardiovascular magnetic resonance: administered dose in relationship to united states food and drug administration (FDA) guidelines
de réir: Nacif Marcelo S, et al.
Foilsithe / Cruthaithe: (2012-02-01) -
Toxicity associated with gadolinium-based contrast-enhanced examinations
de réir: Silvia Maria Lattanzio
Foilsithe / Cruthaithe: (2021-05-01)